Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: J Virol Methods. 2015 Sep 3;225:41–48. doi: 10.1016/j.jviromet.2015.08.025

Table 2.

YF MAC-HD results of serum samples from confirmed flavivirus and Malaria infections.

Sample Confirmed Dx Dx result* YF MAC-HD P/N
1 DEN 62.1 3.7
2 DEN 58.9 1.1
3 DEN 11.6 2.2
**4 DEN 15.1 14.1
5 DEN 19.3 4.1
6 DEN 19.4 9
7 DEN 16.7 2.9
8 DEN 11.5 3.2
9 WN 9 5.7
10 WN 4.7 1
11 WN 6.4 0.9
12 WN 21.2 12.6
13 WN 22.4 0.5
14 WN 3 1
15 WN 7.4 0.9
16 ZIKA 12.1 0.7
17 ZIKA 11.1 ***1.2
18 ZIKA 6.6 0.6
19 ZIKA 8.1 3.6
20 ZIKA 36.1 0.6
21 ZIKA 4.4 0.7
22 ZIKA 15.6 0.6
23 ZIKA 13.3 7.2
24 Malaria POS 0.8
25 Malaria POS ***bkgd
26 Malaria POS 1
27 Malaria POS 0.6
28 Malaria POS 0.6
29 Malaria POS 0.8
30 Malaria POS ***bkgd
31 Malaria POS ****4.2
*

Diagnostic results presented are IgM ELISA P/N for DEN, WN and ZIKA where P/N 2.0>=3.0 is equivocal and P/N>=3.0 is positive; CareStart rapid antigen test was used for malaria

**

Sample 4 is a secondary DEN infection as determined by PRNT where there is a <4-fold difference in titer between results for each of the 4 serotypes

***

Samples 17, 25 and 30 were confirmed as negative by YF MAC-ON

****

Sample 31 was negative by YF and DEN1/2 PRNT; positive by YF IgM IFA, positive YF MAC-ON, equivocal by YF CDC MAC-ELISA and negative by WN and DEN CDC MAC-ELISA